Simple and sensitive methods using high-performance liquid chromatography -diode array detection (HPLC -DAD) and ultraviolet (UV) -spectrophotometry were developed and compared to quantify lychnopholide (LYC) in poly-1-caprolactone nanocapsules and to study its release kinetics. Both methods were validated concerning their specificity, linearity, limits of detection and quantification, precision, accuracy and stability. HPLC -DAD analyses were conducted using an RP C18 column, isocratic elution with a methanol-water (60:40 v/v) mobile phase at 0.8 mL/min flow rate and detection at 265 nm. The linear response (r 2 > 0.999) was obtained within a concentration range of 2-25 mg/mL using HPLC -DAD and 5 -40 mg/mL using spectrophotometry. Intra-day and inter-day precision were obtained with low relative standard deviation values. The accuracy of the methods was within the range 98-101% for HPLC -DAD and from 96-100% for UV -spectrophotometry. Both methods were suitable to be applied for the determination of drug loading percentage (>96%) and encapsulation efficiency (>90%). Furthermore, the sensitivity of HPLC-DAD method allows studies of LYC release/dissolution in sink conditions. LYC presented 100% dissolution after 24 h, whereas only 60% of LYC was released from the nanocapsule dosage form, with no burst effect. The methods fulfilled all validation parameters evaluated for LYC quantification in the polymeric nanocapsules and have proven to be accurate, selective and sensitive in the previously mentioned applications.
Introduction
Lychnopholide (LYC) (Figure 1 ) is a sesquiterpene lactone isolated from Lychnophora trichocarpha (1). The genus Lychnophora (Asteraceae) is restricted to the Brazilian Savanna (cerrado biome) and is popularly known as "arnica brasileira" (2) . The in vitro and in vivo effects of LYC have been extensively investigated (3) (4) (5) (6) (7) (8) (9) (10) (11) . It exhibits in vitro activity against Trypanosoma cruzi (3, 4) , fungi (5) and bacteria (6) . Antitumoral, cytotoxic (7, 8) , anti-inflammatory (9, 10) and anti-hyperuricemic (10) activities have also been demonstrated. Canalle et al. (11) have reported clastogenic and cytotoxic effects of LYC in vitro and in vivo.
LYC is classified as a furanoheliangolide that is characterized by the presence of a furanone group in the chemical structure. The activities and toxic effects of LYC (3 -11) are attributed to the presence of two functional alquilant groups, a, b-unsaturated cyclopentenone and a-methylene-g-lactone or a conjugated ester. These groups react with nucleophiles, especially cystein sulfhydryl groups, by a Michael-type addition (12, 13) . LYC is a poor water soluble substance, which renders its administration by an intravenous route difficult. Poor solubility is usually related to low bioavailability per os when administered in conventional pharmaceutical dosage forms. Furthermore, its high pH generally induces a chemical instability of lactones (14) that could be protected by suitable formulation development.
Polymeric nanocapsules (NCs) are colloidal delivery systems used to carry lipophilic drugs, consisting of an oily core surrounded by a polymeric wall (15) . They are generally applied to protect drugs from degradation, to improve water dispersion, to enhance drug absorption and to modify pharmacokinetic and drug/tissue distribution profiles (16) . Among other nanocarriers, NC is advantageous, because it encapsulates higher amounts of lipophilic drugs with low polymer contents and high physicochemical stability (15, 16) .
The present work presents the incorporation of LYC into NC and the investigation of the kinetic profile of its release. This dosage form allows the use of this insoluble drug in colloidal suspensions by parenteral and oral routes. LYC loading in NC and encapsulation efficiency (EE) are two parameters of great significance in the characterization of colloidal nanocarriers (18) (19) (20) that need to be investigated in all steps of formulation development and in the routine analysis of production batches. Therefore, an efficient and simple methodology needs to be established for the quantification of LYC association with NC. Because of the low size of the nanostructures, the methods used to study drug release in conventional dosage forms are not appropriate, and additional separation steps are necessary to isolate drug nanosystems from the release solution. Many techniques, such as gel-filtration, dialysis and ultrafiltration/ centrifugation, are available to separate nanocarriers from external aqueous media (17) . Particularly with very low solubility drugs, these special techniques to study the release from nanocarriers under sink conditions require very sensitive methods for drug quantification. In this situation, the interference of nanoparticle excipients and release medium components in the analysis must be reduced, which is usually achieved with chromatographic separation.
Although LYC has been extensively investigated concerning its biological activities (3 -11) , a validated methodology of LYC quantification, particularly in pharmaceutical dosage forms, has not yet been reported. High-performance liquid chromatography-ultraviolet (HPLC -UV) and gas chromatography (GC) methods have been used to separate and quantify LYC among other complex sesquiterpenoids mixtures from the Lychnophora genus (18) . HPLC -diode array detection (DAD)-mass spectrometry (MS) and HPLC -DAD -tandem mass spectrometry (MS-MS) were the first reported methodologies to quantify LYC in L. ericoides leaves, including a validated method of HPLC -DAD to quantify LYC and other sesquiterpene lactones in leaf extracts of L. ericoides (19) .
Therefore, in this paper, HPLC -DAD and UV -spectrophotometry were proposed and compared to quantify LYC in NC formulations, because simple methods are more affordable for the routine analysis of pharmaceuticals. Furthermore, these methods were applied to the essential determination of encapsulation percentage and efficiency of the process of nanoparticle preparation and to study the drug release rate of LYC from these nanostructures. The application of mathematical models to the release curves of LYC obtained using the HPLC-DAD method was also presented. The primary objective of this paper was the validation of the methods for the quantification of LYC in NC with accuracy and precision, and without interference of NC excipients, which can be applied to the characterization and analysis of this new pharmaceutical formulation that is intended to be used in preclinical tests.
Materials and Methods

Chemical and reagents
Hexane, ethyl acetate, acetone and methanol, all analytical grade, were purchased from Vetec (Rio de Janeiro, Brazil). Acetonitrile (MeCN) and HPLC-grade methanol were supplied from Tedia (Brazil). The revelators were anisaldehyde and ceric sulphate acid solution, both provided by Vetec. Poly-1-caprolactone (PCL), average Mn 42,500 g/mol, Poloxamer 188 (non-ionic surfactant) and Tween 80 were provided by Sigma-Aldrich (St. Louis, MO); Epikuron 170 (70% soy phosphatidylcholine) was supplied from Lucas Meyer (France); Miglyol 810N was purchased from Hulls (Germany). Ultra-purified water was obtained in a Symplicity System 185 (Millipore, Billerica, MA) and used throughout the experiments. 
Plant material
Preparation of the ethanolic extract
The aerial parts of the plant (14.0 Kg) were dried in an oven at 408C, for one week, reduced to powder and then exhaustively extracted with ethanol at room temperature for two weeks. The solvent was removed under reduced pressure in a rotary evaporator, under 408C, to render the dry ethanolic extract (900.0 g).
Isolation and identification of LYC
The ethanolic extract was submitted to column chromatography (CC) over silica gel using hexane, hexane -ethyl acetate (AcOEt) (1:1), ethyl acetate and methanol. By using thin-layer chromatography (TLC), the hexane-AcOEt (1:1) fraction showed spots of sesquiterpene lactone characteristics. This fraction was fractionated on silica gel CC using hexane, ethyl acetate and methanol, increasing the polarity. Elution with hexane -ethyl acetate (80:20) afforded a precipitate. This precipitate was fractionated over silica gel and the fraction was eluted with hexane-AcOEt Solvents, reagents and preparation of NCs NCs were obtained by interfacial polymer deposition following solvent displacement, as previously described by Fessi et al. (22) . NCs were prepared with 80 mg of PCL dissolved in 10 mL of acetone solution containing 75 mg of Epikuron 170, 250 mL of Miglyol 810N and 10 mg LYC. This organic solution was poured into 20 mL of external aqueous phase under agitation containing 75 mg of Poloxamer 188. The solvents were evaporated under reduced pressure (Laborota 4000, Heidolph Instruments, Germany) until a final volume of 10 mL was obtained. Unloaded NCs (blank) were prepared according to the previously described procedure, omitting the LYC incorporation. All formulations were prepared in triplicate.
HPLC-DAD and UV-spectrophotometry conditions
To quantify LYC in pharmaceutical formulations of NC, two analytical methods were developed. The HPLC -DAD method was developed using the HPLC Waters Alliance 2695 system, consisting of a quaternary pump, degasser, automatic sample injector and a column oven. A Waters 2996 spectrophotometric detector with data processing was conducted on an Empower 2 system. Peak areas were automatically integrated by the computer using the Borwin software program. Separation was performed on a C18 Gemini Phenomenex column (150 Â 4.6 mm Â 5 mm) protected by a C18 Phenomenex security guard AJO-7597 pre-column (2 Â 4.6 mm Â 3 mm). The mobile phase consisted of methanol -water (60:40, v/v) with isocratic elution prepared daily and degassed before use. The flow rate and column temperature were 0.8 mL/min and 258C, respectively. The wavelength was set at 265 nm and 20 mL were injected into the chromatographic system. The run time of the chromatography was 10 min. The UV -spectrophotometric analyses were conducted on a Helios a UV-VIS spectrophotometer (Thermo Spectronic, Palo Alto, CA).
Validation
The current pharmaceutical guidelines of the International Conference of Harmonization (ICH) (23) include several parameters to validate analytical methods, such as specificity, linearity, limit of detection (LOD), limit of quantification (LOQ), precision, accuracy and stability. A comparison between the two analytical methods (HPLC -DAD and UV -spectrophotometry) was also performed to demonstrate the adequacy of the methodologies for the intended purpose.
Specificity or selectivity
To select the wavelength that allows the maximum absorption of LYC in UV, scans were conducted in a range of 200-400 nm using LYC stock solution dissolved in MeCN. The LYC stock solution was prepared at concentration of 25 mg/mL and 1 mg/ mL in MeCN and stored under refrigeration and light protection. These solutions were analyzed by HPLC -DAD and UVspectrophotometry.
To evaluate the specificity, a solution containing unloaded NC and another solution consisting of a mixture of LYC and NC were prepared by dissolution in MeCN. Unloaded NCs were completely dissolved and disrupted in MeCN and analyzed. These solutions were also centrifuged, filtered and injected into the HPLC -DAD and the chromatograms were compared. Possible interferences were investigated in the spectra. Finally, the analyses by UV -spectrophotometry of both solutions were recorded at 265 nm. Three samples of each solution were evaluated by both methods and the mean values were considered.
Linearity
The evaluation of the linearity was conducted considering a data analysis of three calibration curves obtained on three different days for five replicates. For the HPLC-DAD method, eight concentrations of LYC were obtained through appropriate dilutions in MeCN of the stock solution of LYC (2, 3, 4, 7.5, 10, 15, 20 and 25 mg/mL). Aliquots of the stock solutions were diluted in MeCN in the concentration range from 5 to 40 mg/mL (5, 7.5, 10, 15, 25, 35 and 40 mg/mL) for the UV -spectrophotometric analysis. Calibration curves were plotted for each method and the obtained data were submitted to regression analysis using the minimum square method. The linearity was expressed as correlation coefficient (r 2 ), considering values higher than 0.99.
LOD and LOQ For HPLC-DAD and UV -spectrophotometric analysis of LYC solutions, calibration curves were prepared with increasing concentrations of 0.02-3 mg/mL and 0.05 -10 mg/mL, respectively. For both methods, the LOD was based on the standard deviation (SD) of the response and the slope of the constructed calibration curve. The LOD was calculated by the following formula:
where s is the SD of the response and S is the slope of the calibration curve (1). The LOQ for both methods was also determined in similar conditions until the lower level was detected with acceptable precision and accuracy. The LOQ was estimated by using the SD of the response and the slope of the constructed calibration curve calculated by Equation (2).
Precision
The precision was determined by the analysis of the LYC solution at three different concentrations and over five replicates (n ¼ 5) on the same day (intra-day precision) and on two consecutive days (inter-day precision). For both analyses, the concentrations of LYC solutions were low (3 and 7.5 mg/mL), medium (10 and 15 mg/mL) and high (20 and 35 mg/mL) for HPLC-DAD and UV -spectrophotometric analysis, respectively. The results were expressed as the relative standard deviation (RSD) of the data, obtained according to the following formula:
where mC is the medium concentration. The acceptable values for the RSD are lower than 2%.
Accuracy
The accuracy was evaluated by a recovery test. Unloaded NCs were spiked with known amounts of LYC at three different concentrations (low, medium and high) and the analyses were performed in five replicates for each concentration. For the HPLC-DAD method, the NC spiked with known concentrations of LYC were analyzed at 3, 10 and 20 mg/mL. The UV -spectrophotometric analysis was also performed in five replicates at LYC concentrations of 7.5, 15 and 35 mg/mL. The percentages of recovery (R) were calculated using the following formula:
where Snc is the spiked nanocapsule, UnC is the unloaded nanocapsule and Ss is the standard solution of LYC. The 95 to 105% are the acceptable variation in measured concentrations.
Stability
The stability stock solution of LYC was analyzed after its exposure for four days at room temperature and 2 -88C. It was compared with the analysis of freshly prepared stock solution at low (3 and 7.5 mg/mL), medium (10 and 15 mg/mL) and high (20 and 35 mg/mL) LYC concentrations using both methods. The post-preparative stability of samples was evaluated by injection immediately after preparation and re-injection after storage in an autosampler for 24 h. Each analysis was conducted in five replicates. The stability was determined based on the LYC peak areas and retention times in comparison with freshly prepared solutions.
Applications
Encapsulation percentage and determination of encapsulation efficiency using HPLC-DAD and UV-spectrophotometry methods The quantification of LYC in the polymeric NC of PCL-NC was performed by HPLC -DAD and UV -spectrophotometry methods developed. The encapsulation percentage of LYC loaded in NC was calculated as the difference between the total drug in the final colloidal suspension and the free drug in the external aqueous phase. Non-encapsulated LYC can be found dissolved in the external aqueous phase or precipitated. The fraction of LYC dissolved in the external phase (ultrafiltrate) was assessed by 400 mL NC samples ultrafiltrated in an AMICOM device (Microcon Ultrafilter 50,000 MWCO, Millipore) centrifuged at 500 Â g for 30 min. The LYC associated with the NC was retained in the upper compartment of the device. The percentage of LYC loaded on the NC (encapsulated) and encapsulation efficiency were determined by Equations (5) and (6), where A is the LYC concentration (mg/mL):
To determine the total amount of LYC in the NC, 125 mL of the NC suspension was added to 5 mL of MeCN, mixed in a vortex for 5 min (Vortex Instrument, IKA, Germany) to disrupt the NC and release the drug. The sample was centrifuged and 25 mL of the supernatant was injected into the HPLC -DAD system or analyzed through UV -spectrophotometry. For quantification of the LYC not encapsulated, 20 mL of the ultrafiltrate was mixed with 980 mL of MeCN. The mixture was centrifuged and the supernatant was assayed using HPLC-DAD and UV -spectrophotometry. The analysis was performed in triplicate. The amount of LYC adsorbed in the ultrafiltration membrane of the AMICON device was also quantified. The membrane was removed from the device, rinsed with MilliQ water, dried, immersed in 0.5 mL of MeCN, vortex-mixed for 15 min and centrifuged, and the LYC content in the supernatant was assayed.
LYC release kinetics from NCs in vitro Previously, solubility tests of LYC were performed in the release medium over 24 h in phosphate buffered saline (PBS) at pH 7.4 and in PBS at pH 7.4 containing 0.5% Tween80. LYC (2.5 mg) was accurately weighed and maintained under stirring in 1 mL of the media for 24 h. At the end of this period, the sample was centrifuged for 15 min at 8.000 rpm; 100 mL of the supernatant was withdrawn, diluted in a volumetric flask with MeCN up to 2 mL and quantified by HPLC -DAD. This experiment was conducted in triplicate and the results were expressed as mean and SD. The evaluation of in vitro release kinetics of LYC from NC was performed according to the technique of direct equilibrium dialysis (17) and quantified using only the HPLC-DAD method. NC (1 mL) was added to dialysis bags with of 12,000 -14,000 of MWCO. A total concentration of 20 mg/mL of LYC was used in the medium, to obey sink conditions (20% of maximal solubility of LYC in PBS-Tween80). These dialysis bags were immersed in 50 mL of the release medium and kept under mild agitation in a shaking bath at 37 + 0.58C (Dubnoff Bath, Fanem, Brazil). At each time interval (0.25, 0.5, 1, 3, 6, 9, 12, 21, 24 and 48 h), aliquots of 1 mL were taken from the external medium and volumetrically diluted with MeCN to obtain a final volume of 2 mL, which was mixed and ultra-centrifuged (3,500 Â g) and the supernatant was analyzed by HPLC-DAD. The LYC release experiments were performed in triplicate. Mathematical modeling of the release and dissolution data of LYC was performed using theoretical models: zero order, first order, Higuchi and Power law (24) .
Results and Discussion
The analysis of the melting point (128-1298C), the infrared spectra, MS and 1 H and 13 C NMR data confirmed the chemical structure ( Figure 1 ) and purity of LYC used in this experimental work by comparison with previously published data (20, 21) . Figure 2 shows the ultraviolet absorption spectrum of LYC in the range of 200-400 nm. The maximal absorption wavelength of 265 nm was selected for quantification of LYC in both methods because of its selectivity in the presence of NC excipients.
Method validation
Specificity in the HPLC-DAD method was evaluated in chromatograms using LYC solutions compared with LYC loaded in NC. The chromatograms showed that no other compound co-elutes with the primary peak of LYC ( Figure 3A) . Furthermore, the chromatogram obtained for the mixture of unloaded NC and LYC solution showed no interfering peaks at the same retention time of LYC ( Figure 3B ). Even in a release medium of PBS containing 5% (v/v) of Tween80 after 48 h of incubation, no degradation products or new peaks appear and no interference of surfactant or compounding NCs ( Figure 3C) were observed. The same wavelength for detecting LYC was described previously by Santos et al. (18) . These authors used gradient elution and a higher run time of 60 min. In this study, a 10 min run time was used throughout. Gobbo-Neto and Lopes (19) developed a method for the extraction and HLPC-DAD analysis of secondary metabolites of L. ericoides leaves. This analytical method was validated in the presence of 11 secondary metabolites of this plant, including LYC, employing an eluent phase of 2:88:10 acetic acid-MeCN-methanol (v/v). However, under these chromatographic conditions, LYC presented a retention time of 101 min. In this work, different proportions of methanol and water were tested and the combination of 60:40 methanol -water resulted in one symmetrical peak and an adequate retention time of 6.9 min for LYC ( Figure 3 ) under the current experimental conditions. Thus, an isocratic methodology for LYC quantification with a low retention time offers important advantages over the previous studies (18, 19) , in terms of solvent consumption.
Concerning the UV method, no other absorption band was found at 265 nm. Therefore, the method was selective to quantify LYC at this wavelength, even in the presence of the NC excipients. However, when using LYC-loaded NCs, the particles must be disrupted with acetonitrile before analysis because this has high turbidity.
A linear relationship was found between the concentration of LYC and the response of the proposed quantification methods, HPLC-DAD and UV -spectrophotometry in the ranges of 2 -25 and 5-40 mg/mL, respectively. Table I shows the data of regression analysis. No significant deviation of linearity was detected at this condition. It was possible to quantify lower concentrations of LYC using HPLC-DAD than when using UV -spectrophotometry, but samples with concentrations higher than 25 mg/mL needed to be diluted to be analyzed by the HPLC-DAD method. The LODs obtained for HPLC-DAD and UVspectrophotometry methods were 0.5 and 1.0 mg/mL, respectively. According to the results, HPLC-DAD proved to be a more sensitive method, allowing the quantification of LYC in NC formulations at concentrations approximately five times lower than the UV -spectrophotometry method (Table I) . Table II shows the data of precision obtained with the HPLC-DAD and UV -spectrophotometry methods. All concentrations of LYC analyzed under all evaluated conditions were within the acceptable precision range. Both HPLC-DAD and UV -spectrophotometry methods exhibited mean recoveries (n ¼ 5) within the acceptable accuracy range (95 to 105%). Both methods showed intra-day and inter-day precision with low RSD values (Table II) . The stability of LYC standard solutions under experimental conditions was evaluated at three concentrations for both methods. The results showed that the RSD was less than 1.5% for LYC, what indicates that the solutions are stable within the given period (Table III) using both methods. No signs of product degradation or drug loss were observed, which confirms the stability of LYC.
Application of the methods
LYC encapsulation percentage and efficiency
The evaluation of the nanocarrier drug payload is an essential physicochemical parameter in the development of a new drug delivery system. Table IV shows the results obtained using both methods in the determination of the percentage of encapsulation (drug loading) and encapsulation efficiency, which takes into account the drug losses in the preparation process for NCs. No significant difference (P . 0.05) was found between the methods in the evaluation of encapsulation percentage and efficiency. High percentages of encapsulation at 1 mg/mL were obtained due to the high lipophilicity of LYC (log P ¼ 5.03 calculated with ACDLab software). This indicates that LYC has more affinity for the oily core of PCL NC than for the external aqueous medium. Thus, both methods were applicable for the determination of LYC in NCs. In such situations, UV -spectrophotometry is a very simple and rapid method that is advantageous in terms of cost in routine analysis. In vitro release kinetic study A well designed nanocarrier system should not only be able to incorporate a high payload of the drug, but should also be able to release it at an appropriate rate under physiological conditions (15) . The low solubility of LYC in PBS at pH 7.4 (33 + 1.3 mg/mL) and the high LOQ in HPLC -DAD (2 mg/mL) increase the difficulties of LYC quantification that must be surmounted in dissolution/release studies. To obtain sink conditions (20% of saturation solubility) in this case, the release medium have to be modified with addition of Tween80 0.5% (v/v). In this medium, LYC solubility increases to 100 + 3.5 mg/mL. The LYC dissolution profile and the release profile of LYC from NC are shown in Figure 4 . There is a significant difference in the amount of LYC released and dissolved (P , 0.001). After 24 h, approximately 100% of LYC was completely dissolved, whereas approximately 60% was released from NC ( Figure 4 ). The analysis of the dissolution profile indicates that diffusion through membranes (dialysis) occurs slowly, and the complete dissolution occurs only after 24 h of contact with the medium, even in sink conditions. The release profile of LYC from NC is very different and shows retention of the drug inside the nanocarrier, even in sink condition. No release was observed during the first 3 h, compared with 40% LYC dissolution. The initial burst is negligible in NC release, which indicates that LYC was not adsorbed at the surface of the NC, but it has strong association with the inner core of the NC. After that, the release was slow and sustained from the NC, reaching only 15% release after 12 h, compared to 70% dissolution. Although the release of LYC from NC was slow, it was complete, resulting in the release of 97% of this substance in 48 h. The times required for the release of 50% of the encapsulated LYC (T 50 ) were found to be 20.7 and 7.3 h for LYC dissolution. In the case of LYC release studies, HPLC with DAD was found to be more appropriate than UV -spectrophotometry to quantify small amounts of drugs in aqueous media, providing more sensitivity.
Mathematical analysis of LYC release kinetics was performed using the following four models: zero-order kinetics, first-order kinetics, Higuchi and Korsmeyer-Peppas (Power law). Table V  presents regression coefficients (r  2 ) , the release constants (k 0 , k 1 , k H and k values) and n, which is an exponent characterizing the diffusional kinetic mechanism, calculated by fitting the release data into the Korsmeyer-Peppas equation (24) . Regression coefficient analysis indicates that the zero order and Power law models were best fitted with the LYC release kinetics from NC, indicating that the predominant mechanism of the drug release from this system was the diffusion through the polymeric NC wall. The n value, calculated using an interval of 6-48 h, indicates that LYC has to diffuse through polymeric chains following anomalous transport (Table V) , according to Costa and Lobo (24) . NC represents an additional barrier to diffusion, compared to the profile of free dissolution of the drug. Cruz et al. (26) previously discussed that the thickness of the polymeric wall can influence the diffusion rate of the NC. The thicker the polymeric wall, the higher the half-life of the burst phase of release, and the affinity by the oil increases the half-life of the sustained phase (26) . In the case of LYC NC, a high affinity for the oil is observed. PCL is a slowly degrading polymer and one of the most hydrophobic among the biodegradable polyesters. Its wall probably impairs and influences the diffusion of LYC. The kinetic was assumed to be an apparent zero-order rate (r 2 ¼ 0.9632) according to mathematical modeling of the data (Table V) taking all time intervals into consideration. The results of the present work are different from several other polymeric NC formulations in which the drug clearly influenced the surface, and burst release was usually greater than 20% (16, 25) . Thus, the mechanism probably involves partitioning of LYC between the oily core and the external medium through the polymeric wall of the NC (15), with minimal adsorption at the surface of the NC. These aspects of the developed LYC NC formulation can be used to obtain a controlled release in the gastrointestinal tract or upon parenteral administration, reducing undesirable burst releases and drug degradation/elimination before reaching target sites.
Conclusion
In conclusion, this study presented two simple, specific, precise and accurate methods for the quantitative determination of LYC in NCs. These methods can be applied to quality control analyses of the NC dosage forms, with the aim of quantifying LYC. The UV -spectrophotometry was suitable to determine encapsulation efficiency and drug loading; however, HPLC-DAD was more sensitive to quantify LYC in dissolution/ release studies, in which very small amount of drug is released over time. Furthermore, the methods fulfilled all validation parameters evaluated for the quantification of LYC in the polymeric NC and were proven to be accurate, selective and sensitive in the proposed applications.
